✦ LIBER ✦

Pharmacokinetics of cefotaxime in patients after liver transplantation

✍ Scribed by E. Kuse; P. Vogt; B. Rosenkranz

Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 818 KB
Volume: 18
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01647000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of tacrolimus in liver

Pharmacokinetics of tacrolimus in liver transplant patients*

✍ Jusko, William J.; Piekoszewski, Wojciech; Klintmalm, Goran B.; Shaefer, Mark S. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 784 KB

## Pharmacokinetics of tacrolimus in liver transplant patients O&e&ve,e: To characterize the pharmacokinetics of the immunosuppressive agent tacrolimus (IX 506) in liver transplant patients. Metboh: Patients (n = 16) were assessed during and after l-to 3&y intravenous infusions followed by a 2-wee

Patient survival after tertiary liver tr

Patient survival after tertiary liver transplantation

✍ Kumar, Nagappan ;Wall, William J. ;Grant, David R. ;Ghent, Cameron N. 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 29 KB

## To the Editors: De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and econ

Critical care issues in patients after l

Critical care issues in patients after liver transplantation

✍ Raymund R. Razonable; James Y. Findlay; Aisling O'Riordan; S. Gordon Burroughs; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

Pharmacokinetics of mycophenolic acid in

Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil

✍ Ashok Jain; Raman Venkataramanan; Tai Kwong; Ravi Mohanka; Mark Orloff; Peter Ab 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

The bioavailability of mycophenolic acid (MPA) after oral administration of mycophenolate mofetil (MMF) has been reported to be more than 90% in healthy volunteers, and in kidney and thoracic organ transplant patients. Such information is limited in liver transplant (LTx) patients. The present study

Comparison of immune reactivity and phar

Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation

✍ Ruth Adler; Rifaat Safadi; Yoseph Caraco; Mina Rowe; Amos Etzioni; Yaffa Ashur; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Hepatitis B virus (HBV) immune globulin (HBIg) administration will prevent HBV graft reinfection in HBV patients after orthotopic liver transplantation (OLT). However, the expenditure for such prophylaxis is extremely high ranging between $2,000 to $10,000 per month in various countries for an undef

Splanchnic hyperemia after liver transpl

Splanchnic hyperemia after liver transplantation in patients with end-stage liver disease

✍ Alvarez, Daniel ;Gerona, Solange ;Waisburg, Zulema ;Ciardullo, Miguel ;Santibañe 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 112 KB 👁 2 views

Systemic and splanchnic hemodynamic parameters were evaluated in 12 patients with cirrhosis before and 3 and 6 months after liver transplantation. Results were compared with those obtained in 8 healthy subjects. Three months after liver transplantation recipients had an increase in mean arterial pre